Expectancies and memory for an emotional film fragment: a placebo study by van Oorsouw, K.I.M. & Merckelbach, H.L.G.J.
  
 
Expectancies and memory for an emotional film
fragment: a placebo study
Citation for published version (APA):
van Oorsouw, K. I. M., & Merckelbach, H. L. G. J. (2007). Expectancies and memory for an emotional film
fragment: a placebo study. American Journal of Psychology, 120(2), 287-301.
https://doi.org/10.2307/20445399
Document status and date:
Published: 01/01/2007
DOI:
10.2307/20445399
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
AMERICAN JOURNAL OF PSYCHOLOGY
Summer 2007, Vol. 120, No. 2, pp. 287–301
© 2007 by the Board of Trustees of the University of Illinois
Expectancies and memory  
for an emotional film fragment:  
A placebo study
KIM VAN OORSOUW ANd HARALd MERCKELBACH
Maastricht University
This study investigated whether positive (“memory-enhancing”) and negative 
(“memory-impairing”) placebos may enhance and undermine, respectively, mem-
ory of a film fragment. After watching an emotional film fragment, participants 
were assigned to a “memory-enhancing” placebo group (n = 30), control group 
(n = 30), or “memory-impairing” placebo group (n = 30). Only participants who 
believed in the placebo effect were included in the analyses. In the positive pla-
cebo group, memory for the film fragment was better than that of participants 
who received negative placebos or control participants. Participants in the nega-
tive placebo group made more distortion errors than participants in the positive 
placebo or control group. Our findings show that people’s expectancies about 
their memory may affect their memory performance. These results may have 
implications for both clinical practice and the legal domain.
Several studies suggest that expectancies can affect memory performance. 
According to Ponds, Van Boxtel, and Jolles (2000), older adults often 
evaluate their cognitive functioning more negatively than younger peo-
ple, when in fact there is no substantial difference between these groups 
in their performance on objective memory tasks. Meanwhile, the pes-
simistic expectations of older adults (e.g., fear of dementia) may under-
mine their daily memory functioning in cognitive demanding situations. 
Other studies have found that beliefs about memory functioning—so-
called metamemory beliefs—can be experimentally manipulated such 
that people come to evaluate their memories to be less available. For 
example, Winkielman, Schwarz, and Belli (1998) showed that successful 
retrieval of many childhood memories can paradoxically induce the belief 
in participants that their memory of childhood is poor. This paradoxical 
effect has to do with participants attributing the cognitive effort needed 
for memory retrieval to the quality of their childhood memories (see also 
Belli, Winkielman, Read, Schwarz, & Lynn, 1998; Winkielman & Schwarz, 
2001). van Oorsouw and Merckelbach (2006) found that the paradoxical 
effect of memory retrieval is not an inert side effect but can undermine 
subsequent performance on an autobiographical memory task.
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 Expectancy effects have been investigated with the use of placebos 
(Brown, 1998). A placebo is an inactive substance that is presented to 
participants or patients as an active drug. In pharmacologic studies, a 
placebo condition usually is used to differentiate genuine effects related 
to the pharmacologic properties of a drug from the expectancy effects 
that occur when patients are administered a drug. When the patient’s 
health improves after administration of a placebo, this improvement is 
not attributable to the intrinsic properties of the drug but to explicit 
beliefs or expectancies about the effects of the placebo. Although this 
is often called the placebo effect, in a strict sense such an effect can be 
established only when patients in a placebo condition improve more than 
those in a no-treatment control group (Kirsch & Lynn, 1999; Stewart-
Williams & Podd, 2004).
 Although in clinical trials, physiologic (e.g., blood pressure) and emo-
tional (e.g., pain sensation) placebo effects have been well documented 
(e.g., de Craen, Kaptchuk, Tijssen, & Kleijnen, 1999; de Jong, van Baast, 
Arntz, & Merckelbach, 1996; Pope & McNally, 2002), placebo effects on 
cognitive functioning (e.g., memory) have been studied less well. One 
exception is the study of Assefi and Garry (2003), who found that the belief 
of having consumed alcohol, when in fact the drink was a nonalcoholic 
beverage, made participants more susceptible to misleading postevent 
information. Assefi and Garry argued that the social context is critical to 
the placebo effect they found because no effect of the alcohol placebo 
was found on memory for control events (i.e., no misinformation). That 
is, the mere belief that they had consumed alcohol in combination with 
suggested misinformation may have increased participants’ tendency to 
accept misinformation from the experimenter. Accordingly, Assefi and 
Garry concluded that “alcohol placebos did not affect memory per se, 
but influenced participants’ tendency to capitulate to suggestions made 
by the experimenter” (p. 79).
 Another study in this domain is that by Kvavilashvili and Ellis (1999), 
who investigated the placebo effect on cognitive performance in a de-
sign that did not include social suggestions provided by others. These 
authors gave participants a placebo capsule and told them explicitly that 
it would improve or impair their memory for a list of words. They only 
found significant effects on actual performance in the condition in which 
memory impairment expectancies had been created. Here, participants 
recalled fewer previously learned words than participants in the control or 
positive placebo condition (i.e., a memory quantity effect), and they also 
tended to make more commission errors (i.e., a memory accuracy effect). 
For participants who had received “memory-improving” instructions, no 
positive placebo effect on memory performance was evident. In contrast, 
Green, Taylor, Elliman, and Rhodes (2001) did find a positive placebo 
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effect when studying the effects of glucose on cognitive functioning. Par-
ticipants who received glucose performed better than participants who 
were given a placebo and were told it was a placebo. However, another 
group, which was given a placebo but was told it was glucose, also per-
formed better than the told-placebo group. This indicates that the mere 
suggestion of receiving glucose when in fact it is a placebo may improve 
cognitive functioning.
 So far, the published studies on placebos and memory have relied heav-
ily on static memory material (e.g., word lists, slides). The aim of the pres-
ent study was to investigate expectancy effects of “memory-enhancing” and 
“memory-impairing” placebos on memory for an emotional film fragment. 
Based on previous studies examining placebo effects and memory, we 
predicted that in comparison to a no-treatment control group, “memory-
enhancing” placebos would improve memory for the film fragment (i.e., 
more correctly recalled details and less commission and distortion errors 
than in the other groups), whereas “memory-impairing” placebos would 
worsen memory for the film fragment (i.e., fewer correctly recalled de-
tails and more commissions and distortions than in the other groups). 
We measured three types of dependent variables: objective memory per-
formance, subjective memory estimates, and subjective memory effort. 
The last variable was included to control for reversed placebo effects. 
These occur when positive placebos impair and negative placebos im-
prove participants’ memory as a result of decreased or increased effort 
in retrieving information (Kvavilashvili & Ellis, 1999). If reverse placebo 
effects occurred, one would also expect group differences in the amount 
of effort, with the positive placebo group reporting less effort than the 
negative placebo group.
 The scarce experimental literature on placebos and memory shows that 
one has to differentiate between two levels at which effects might occur. 
One level is that of objective performance (e.g., memory performance on 
a word list task). The other level is that of expected or perceived efficacy 
of the placebo and has more to do with subjective beliefs and expectan-
cies (i.e., metamemory). Both levels might be partially or completely dis-
sociated. For example, in the Kvavilashvili and Ellis (1999) study, those 
who had a positive placebo tended to report that it had improved their 
performance, whereas those who had a negative placebo tended to report 
that it had undermined their performance. Yet at the level of objective 
memory performance, only negative placebos were found to undermine 
free recall of learned words. Likewise, in a study by Greenwald, Spangen-
berg, Pratkanis, and Eskenazi (1991), participants who were given sublimi-
nal self-help tapes to improve their memory subsequently indicated that 
their memory had improved, although this was not reflected in objective 
measures of memory. Although subjective and objective placebo effects 
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might be dissociated, one may safely assume that objective placebo effects 
occur only to the extent that participants believe that the placebo will be 
or has been effective to begin with. Assuming that objective placebo effects 
critically depend on subjective expectancies, the current study included 
participants on basis of the latter variable. That is, only participants who 
believed the placebo to be effective were included in the main analysis.
 Previous placebo studies (Assefi & Garry, 2003; Kvavilashvili & Ellis, 
1999) manipulated expectancies at or before encoding. In such design, 
beliefs about “memory-enhancing” or “memory-impairing” drugs could 
affect encoding, retrieval, or both. In the current study, we administered 
placebos after encoding of the emotional film material. The reason for 
doing so was our interest in real-life situations such as eyewitnesses re-
porting about a crime that they saw. In the forensic literature, one can 
find many examples of authors claiming that drugs such as barbiturates 
may help eyewitnesses or defendants to recover previously lost memories 
about an emotional event (for a review, see Kihlstrom, 1998). One simple 
explanation for these memory-facilitating phenomena is that they reflect 
positive placebo effects.
EXPERIMENT
METHOD
Design and procedure
 The study was approved by the standing Ethical Committee of the Faculty of 
Psychology, Maastricht University. Participants (N = 90; 73 women, 17 men) vol-
unteered to participate in an experiment that was announced as a study on mem-
ory-improving and memory-impairing drugs. Participants were first screened by 
telephone. This telephone interview was conducted to enhance the belief that real 
drugs were being tested. Thus, during the telephone interview, participants were 
asked whether they were pregnant, suffered from epilepsy or depression, and were 
using medication (for a similar procedure, see Kvavilashvili & Ellis, 1999). When 
all these questions were answered negatively, they were allowed to participate in 
the study. Participants were instructed not to drink beverages containing alcohol 
or caffeine up to 4 hr before the experiment because this could affect memory 
performance. We selected participants who believed the placebo instructions.
 When participants came to the lab some days later, they were informed about the 
procedure. They were told that they might be assigned to one of the two groups 
that were going to test a new drug, but they might also be assigned to a control 
group that would not test any drugs. Participants filled out informed consent forms 
and were asked whether they had any questions about the drugs they might be 
asked to take. The first part of the experiment, the encoding phase, consisted of 
watching a film fragment. Participants were told that they were about to watch an 
emotional film fragment. Nothing was mentioned about any upcoming memory 
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tests for this fragment. Next, expectations about memory were manipulated by 
administering the “memory-enhancing” (positive) or “memory-impairing” (nega-
tive) placebos. Finally, memory for the encoded material was tested.
 The film fragment (duration about 3 min) was an emotional scene taken from 
the movie American History X. The fragment was about a neo-Nazi shooting two 
black men who were trying to steal his car. This film fragment has been used in 
previous studies in our lab (Giesbrecht, Geraerts, & Merckelbach, in press; Smeets, 
Candel, & Merckelbach, 2004). On the basis of this previous work, we have devel-
oped a scoring protocol for evaluating memory data about the fragment. After 
participants had seen the fragment, they were asked to rate on two 100-mm visual 
analog scales (VASs; anchors 1= not emotional/realistic, 100 = very emotional/realistic) 
how emotional and realistic they thought the fragment was. Next, participants 
were randomly assigned to one of the three groups by drawing an envelope from 
a box. The experimenter was blind to the content of the envelopes. The envelope 
contained instructions and a placebo capsule in the experimental groups or only 
instructions in the control group. Participants were asked to open the envelope, 
read the instructions, and take the capsule, if any, with some water. In the positive 
placebo group, instructions were as follows: “You are in the memory-enhancing 
group. You are testing a homeopathic drug, called MEMOLIN, which is known 
to stimulate memory performance. It increases the transmission of serotonin and 
acetylcholine in the brain, compounds that are important for memory processes.” 
The negative placebo group received the following instructions: “You are in the 
memory-impairing condition. You are testing a food supplement, called SERUNUL 
[from Kvavilashvili & Ellis, 1999], of which the most important side effect is that it 
briefly suppresses memory performance. It reduces the transmission of serotonin 
and acetylcholine in the brain, compounds that are important for memory pro-
cesses.” The following instructions were similar for both groups: “The drug has 
no bodily side-effects we know of. However, if you do experience any side effects, 
we ask you to report them in the exit interview. It takes approximately 30 minutes 
for the drug to cross the blood–brain barrier. So, after 30 minutes from now we 
will start with the memory testing. After two to three hours, the drug will lose its 
effect. Please take the capsule orally with some water and fill out the question 
below and close the envelope. do not tell the experimenter in which condition 
you are.” After participants had read the instructions, they answered a question 
that was on the instruction form. The question was about how much effect they 
expected the capsule to have on their memory performance. Instructions in the 
envelope the control groups received read as follows: “You are in the control group, 
which means that you are not testing any drugs. However, similar to participants 
in the other two groups you are asked to wait for 30 minutes. After 30 minutes 
the memory testing will start.”
 After participants had closed the envelope, an interval of 30 min followed. 
during the interval, all participants filled out a few questionnaires that were not 
related to memory and will not be considered further here. When participants had 
finished the questionnaires within the 30-min period, they were asked to remain 
in the room and were given some magazines to read. during this stage of the ex-
periment, participants were never told that the memory test would pertain to the 
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film fragment. To enhance the belief that real drugs were used, blood pressure 
was measured immediately before the placebo was administered (baseline) and a 
second time after the 30-min interval had elapsed, when the drugs had supposedly 
crossed the brain barrier. Participants were told that it was necessary to closely 
monitor their physiologic responses to the drug or that blood pressure served 
as a control measure in case they would not receive a drug (i.e., in the control 
group). Therefore, baseline blood pressure was measured for all participants before 
they knew to which group they were assigned. during the 30-min interval, the 
experimenter stayed in the room with the participant, who was told that this was 
done so that quick action could be taken in case he or she experienced any side 
effects. After 30 min had passed, participants were told that their memory for the 
film fragment would be tested. They were asked to write down everything they 
could remember of the film fragment. Participants were instructed to describe the 
events, people, and surroundings in as much detail as possible. Finally, participants 
underwent an exit interview. As part of this interview, they completed questions 
about how much effort they had put into completing the memory test (anchors: 
0 = no effort, 7 = very much effort), how effective they judged the drug to have been 
in affecting their memory (anchors: 0 = no effect, 7 = very powerful), and whether 
they had any ideas about the research questions. After this, participants were fully 
debriefed and were given their credit hour.
Statistical analysis
 Blood pressure was analyzed using a 3 (groups) × 2 (baseline vs. follow-up) 
analysis of variance (anova) with repeated measures on the last factor. Free recalls 
of the film fragment were subjected to a one-way anova with the three groups (i.e., 
positive placebo, negative placebo, and control group) as independent factor. To 
identify specific differences between groups, follow-up pairwise comparison t tests 
with Bonferroni corrections (a = .01) were carried out. Ratings of emotionality 
and realism of the film fragment, expected effect, and experienced influence were 
evaluated with one-way anovas or independent sample t tests in case comparisons 
involved only the two experimental groups.
RESULTS
Participants
 In total, 90 undergraduate students (73 women, 17 men) participated 
in the experiment. Their mean age was 19.7 years (SD = 2.5, range, 17–32 
years). Participants received 1 course credit hour for their participation. 
Only participants who expected the drug to be more than slightly effective 
(ratings higher than 3) were included in the main analysis. Participants 
who did not believe in the memory-enhancing or memory-impairing prop-
erties of the placebos were excluded.1 Indeed, there was a significant in-
teraction effect between beliefs about the placebo’s effectiveness (ratings 
of 3 or less or ratings greater than 3) and the placebo groups’ (positive or 
negative) free recall performance, F(1, 58) = 7.37, p < .05. This shows that 
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the placebo’s effect on objective memory performance depended on the 
a priori beliefs participants held. Therefore, further analyses were based 
on participants who expected the placebo to be effective. More specifi-
cally, there were 13 participants2 in the positive placebo group, 15 in the 
negative placebo group, and 30 in the control group. The mean expected 
effect (anchors: 0 = no effect, 7 = very powerful) was 4.4 (SD = 0.5) and 4.5 
(SD = 0.5) in the memory-enhancing and memory-impairing groups, re-
spectively, t(26) < 1.0.
Blood pressure
 Although blood pressure was measured primarily to create the impres-
sion that real drugs were being administered, it was also used as a measure 
of arousal. To examine whether blood pressure changed as a result of 
placebo administration, a repeated-measure anova was conducted for 
systolic and diastolic parameters separately. We found a main effect of 
time for systolic pressure, F(1, 54) = 14.56, p < .05, and diastolic pressure, 
F(1, 54) = 5.81, p < .05, but no interaction effect (group × time) for sys-
tolic, F(2, 54) < 1.0, or diastolic, F(2, 54) = 1.97, p = .15, pressure.3 Also, 
we did not find main effects of group, both Fs(1, 54) < 1.0. That is, the 
two placebo groups and the control group displayed a decrease in blood 
pressure over time, but this decrease was not modulated by the treatment 
given to participants.
Memory for the film fragment
 The groups did not differ with regard to their emotionality, F(2, 57) < 1.0, 
or realism, F (2, 57) < 1.0, ratings of the film fragment. The mean emotion-
ality and realism ratings of all groups were above 75 on the 100-mm VAS.
 Based on extensive previous work in our lab with the stimulus material 
(see Giesbrecht, Geraerts, & Merckelbach, in press; Smeets, Candel, & 
Merckelbach, 2004), a scoring device was used to evaluate participants’ 
free recall. Two independent raters, who were blind as to the treatments 
given to each participant, coded free recall protocols for the presence 
of 38 crucial pieces of information in the film fragment that would be 
important for a police investigation (e.g., “The neo-Nazi shoots,” “The 
brother was watching,” “The men shot down were black”). For every cor-
rectly reported piece of information, participants received 1 point. To 
obtain a total free recall score, the number of correctly reported pieces 
of information was summed (maximum = 38). Free recall scores were 
transformed into proportions. Also, the number of commission and dis-
tortion errors was calculated. Following the definitions that can be found 
in Gudjonsson and Clare’s (1995) work on false memories and suggest-
ibility, a commission error was defined as the introduction of an entirely 
new but incorrect element, that is, an element that was not part of the 
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film fragment (e.g., “the neo-Nazi pulled one of the men out of the car,” 
when in fact the car got away). A distortion error was defined as a major 
change in details of an existing event (e.g., “the neo-Nazi had a swastika 
tattooed on his upper arm,” when in fact a swastika was tattooed on his 
chest, or “the younger brother was wearing shorts,” when in fact he was 
wearing long pants). The total number of distortion and commission er-
rors was summed.
 Free recall accounts were coded by the first author and a research as-
sistant. Pearson correlations between both raters were .86 for number of 
correctly recalled items, .68 for number of commission errors, and .75 for 
distortion errors (all ps < .01). Because interrater correlations for errors 
were low, we included in our analyses only commission and distortion 
errors that were identified by both raters.
 Proportions of correctly recalled information and number of commis-
sions and distortions are shown in Table 1. For proportion correctly recalled 
information, a one-way anova yielded a significant main effect of groups, F(2, 
57) = 8.03, p < .01, hp2 = .23. Bonferroni corrected post hoc tests (a = .01) 
showed that participants in the positive placebo group recalled more cor-
rect information than either participants in the negative placebo group, 
t(26) = 2.91, p = .01, or participants in the control group, t(41) = 3.59, 
p = .001. The negative placebo and control groups did not differ from each 
other, t(43) < 1.0. No group differences were found for number of com-
mission errors, F(2, 57) < 1.0, hp2 = .03, indicating that positive or negative 
expectations about memory did not lead to more or fewer commissions than 
when no such expectations were induced. For distortion errors, however, 
significant group differences did occur, F(2, 57) = 3.62, p < .05, hp2 = .12. 
Participants in the negative placebo group made more distortion errors 
than control participants, t(43) = 2.44, p = .02, two tailed, and tended to 
make more distortion errors than the positive placebo group, t(26) = 1.84, 
p = .04, one-tailed. The positive placebo group and control group did not 
differ from each other in terms of distortion errors, t(26) < 1.0.4
Table 1. Proportions of correct free recall and number of commission and 
distortion errors (SD) for the positive placebo (n = 13), negative placebo 
(n = 15), and control (n = 30) groups
 Positive placebo Negative placebo Controls
Proportion free recall 0.50 (0.11)a,b 0.41 (0.05) 0.38 (0.09)
Number of commissions 0.38 (0.50) 0.73 (0.96) 0.56 (0.68)
Number of distortions 0.69 (0.63)a 1.33 (1.11)c 0.66 (0.71)
ap < .05 between positive placebo and negative placebo group.
bp < .05 between positive placebo and control group.
cp < .05 between negative placebo and control group.
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Self-report measures
 At the end of the experiment, when participants were asked to evaluate 
how the drug had influenced their memory, both placebo groups rated 
the drug as having been effective in the suggested direction. There were 
no group differences in this respect, t(26) = 1.12, p = .27, with means of 
3.1 (SD = 1.5) and 2.5 (SD = 1.0) for the positive and negative placebo 
group, respectively. The groups did not differ in the amount of effort 
they put into completing the memory tasks, F(2, 57) = 1.69, p = .19, with 
means of 4.8 (SD = 1.6), 4.0 (SD = 1.4), and 4.2 (SD = 1.5) in the positive, 
control, and negative group, respectively.
 There were no significant correlations between the effect that partici-
pants a priori ascribed to the drug and the influence on memory that was 
ascribed to the placebo a posteriori, r = .10, p = .60. Thus, it was not the 
case that participants automatically reported an effect on memory when 
they expected the drug to be effective.5
DISCUSSION
 The results of this study can be summarized as follows. First, taking a 
placebo capsule had no physiologic effects on blood pressure. Second, 
positive placebos had an effect on memory quantity in the sense that 
participants in the positive placebo group recalled more correct informa-
tion about the film fragment than participants in the negative placebo 
or control group. Third, although groups did not differ in number of 
commission errors, participants in the negative placebo group tended to 
make more distortion errors than participants in the positive placebo or 
control group. Thus, negative placebos had a limited effect on memory 
accuracy.
 Our results show that the mere suggestion that a drug improves memory 
has a positive effect on memory performance. Participants in the “memory-
enhancing” placebo group recalled 9% more correct information than 
participants in the “memory-impairing” placebo group and 12% more than 
control participants. As for self-reported changes (i.e., the memory effect 
participants ascribed to the placebo afterwards), we found both positive 
and negative placebos to be mildly effective. Participants who received 
memory-enhancing instructions (i.e., positive placebo group) reported 
an increase in memory performance to the same extent as participants in 
the negative placebo group reported a decrease in memory performance. 
Thus, like Kvavilashvili and Ellis (1999), we found placebo effects in terms 
of self-reported changes in memory. However, in contrast to Kvavilashvili 
and Ellis, we found the positive placebo group to have higher levels of 
correct recall rather than the negative placebo group having lower levels 
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of correct recall. That we could not replicate the negative placebo effect 
on memory quantity reported by Kvavilashvili and Ellis may have to do 
with the fact that we administered the placebo after encoding, whereas 
Kvavilashvili and Ellis gave it before encoding. The memory-undermin-
ing effect of negative placebos in their study may have been caused by a 
decrease in attention, affecting memory encoding and consolidation. In 
our study, participants did not know what type of “drug” they would receive 
when the film fragment was shown to them. Therefore, it is impossible 
that expectancies about the placebo interfered with their encoding of the 
stimulus material. Perhaps, then, negative placebos undermine memory 
quantity only to the extent that they interfere with encoding, whereas 
positive placebos improve quantity only to the extent that they enhance 
retrieval. This issue of how different types of placebos interfere with dif-
ferent memory stages warrants further study.
 Our results replicate those of Kvavilashvili and Ellis (1999) in that we 
too found that negative placebos tend to compromise memory accuracy. It 
has to be added, though, that the memory-undermining effect on accuracy 
that we found was limited to distortions and was not apparent for commis-
sion errors. Furthermore, the effect of negative placebos on distortions 
errors was only borderline significant when Bonferroni corrections were 
made. Another explanation as to why we were unable to find a memory-
undermining effect of negative placebos on recall or commission errors 
may have to do with the type of stimulus material we used. Although we do 
not know how stimulus material might interact with placebo expectancies, 
the fact remains that our stimulus material was emotional and dynamic, 
whereas that of Kvavilashvili and Ellis was neutral and static (i.e., word 
lists). Perhaps the highly effective encoding of emotional material (dolan, 
2002; Hamann, 2001) may have been a safeguard against full-blown com-
mission errors, and this might explain why we did not detect a connection 
between negative placebos and commissions. Clifasefi, Garry, Harper, Shar-
man, and Sutherland (in press) also argue that placebo effects depend 
on the type of stimulus material. Clearly, the precise interactions between 
placebo effects, expectancies, and memory for different types of stimulus 
material deserve further research.
 We can only speculate about the mechanisms responsible for the mem-
ory quantity effect of positive placebos and the memory accuracy effect of 
negative placebos. There were no differences in subjectively reported re-
trieval effort, and therefore this factor cannot explain differential memory 
performance. Although it is often argued that drug effects on memory are 
caused by increases or decreases in arousal and attention (Tinkelberg & 
Taylor, 1984), these factors are unlikely to be responsible for the placebo 
effects on actual memory performance obtained in the current study. After 
all, there were no differences in arousal (i.e., blood pressure) between 
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the two placebo groups after administration of the capsules, indicating 
that manipulating expectations about the drug did not have any differ-
ential effects on arousal. Before and after placebo administration, the 
average blood pressure for all groups was within the normal range (i.e., 
systolic pressure less than 130, diastolic pressure less than 80), although 
all three groups displayed higher blood pressure during the first session. 
One explanation for this higher blood pressure could be the emotional 
film fragment, because negative emotional stimuli are known to increase 
cardiovascular responses (Honda, Masaki, & Yamazaki, 2002). Another 
explanation for the higher blood pressure before placebo administra-
tion could be the anticipation of potential drug intake. In any case, the 
decrease in arousal over time was not caused by the placebo per se. With 
these considerations in mind, we suspect that the placebo effects on ac-
tual memory performance can best be understood in terms of cognitive 
expectancy, attribution, and source monitoring (for a review, see Kirsch 
& Lynn, 1999). For example, in the negative placebo group, participants 
might have thought that distortion errors are acceptable because of the 
memory-undermining drug they had had. A similar pattern was reported 
in Assefi and Garry’s (2003) study in which participants who had had an 
“alcohol” placebo were more likely to accept incorrect information. In a 
recent study, Clifasefi et al. (in press) noted that when participants had 
been given “memory-enhancing” placebos, they were less susceptible to 
misleading information than participants who had been told they received 
a placebo. These authors argued that their positive placebo findings are 
the product of more stringent source monitoring, which would make it 
easier to detect misleading information and to resist misleading sugges-
tions and false memories.
 Admittedly, an expectancy interpretation does not fully account for 
the whole range of findings in our study. The fact that negative placebos 
tended to have an undermining effect on memory accuracy rather than 
memory quantity suggests that apart from expectancies, other factors 
play a role in how placebos affect objective memory performance. As 
mentioned before, one such factor could be the extent to which placebos 
interact with encoding, retrieval, and source monitoring.
 Several limitations of the current study deserve brief comment. To be-
gin with, it is possible that in the positive placebo group, participants re-
hearsed material of the film fragment, thereby leading to superior memory 
performance. On the other hand, during the 30-min interval, participants 
did not yet know that the upcoming memory test would be about the film 
fragment. Nevertheless, because we did not use a demanding filler task, we 
cannot exclude the possibility that our groups differed in their rehearsal 
activities. Second, the placebos in our study were harmless-looking sugar 
capsules. Although our analyses included only participants who said they 
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believed the placebo had been effective, a more powerful manipulation of 
expectancies might occur if one administered placebos with a distinct taste 
or a genuine but harmless side effect (Kirsch & Lynn, 1999). With stronger 
expectancies created, fewer participants would have to be excluded, result-
ing in larger groups and more powerful tests. Third, in our study memory 
testing was done within one session. It would be important to know how 
persistent placebo effects are on actual memory performance. To this end, 
a study involving multiple test sessions would be needed. Fourth, our work 
and that of others (Kvavilashvili & Ellis, 1999; Green et al., 2001) makes 
plain that expectancies set up by placebos may affect objective memory 
performance, but it does little to explain how these effects might occur. 
For example, in our study we did not include confidence ratings as an 
index of source monitoring decisions. Meanwhile, it is conceivable that 
placebo-induced expectancies affect primarily the confidence people have 
in their memory reports. Obviously, this issue warrants further study.
 In sum, placebo participants in our study thought that the placebo had 
affected their memory (i.e., self-reported memory improvement or impair-
ment was evident). Thus, a posteriori, participants reported a slight im-
provement (i.e., positive placebo) or impairment (i.e., negative placebo). 
As Kvavilashvili and Ellis (1999) noted, self-reported effects for both types of 
placebos are not uncommon. Indeed, placebo effects reported in pharma-
cologic studies are revealed more often with subjective reports of changes in 
mood or pain and less so with objective physiologic changes (Ross & Olson, 
1981). From a clinical point of view, subjective metamemory effects are of 
some importance. For example, our finding that the mere expectation of 
memory impairment or improvement leads to corresponding changes in 
self-reported memory performance is relevant to the treatment of older 
adults who have pessimistic ideas about their memory. The participants 
who showed changes in actual memory performance were healthy and 
intelligent undergraduates. It might well be the case that placebo effects 
on memory performance become even more powerful in heterogeneous 
samples (e.g., people with health complaints). With this in mind, it would 
be both interesting and important to conduct placebo memory studies 
in clinical groups. Consider older adults who ruminate about their fear 
of Alzheimer disease (e.g., Ponds et al., 2000) or depressive people who 
have undergone electroconvulsive therapy (e.g., Coleman et al., 1996). 
In these groups, firm beliefs that something is wrong with one’s memory 
might result in a self-fulfilling prophecy. Our findings lead one to wonder 
whether such a self-fulfilling prophecy can be reversed by giving these 
people positive placebos. Or consider perpetrators who report amnesia for 
the crime they have committed. If their amnesia is expectancy based (i.e., 
the perpetrator has convinced himself that his amnesia is profound), then 
changing these expectations using a “memory-enhancing” placebo could 
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perhaps resolve the amnesia. Finally, placebos could be used in eyewitnesses 
who have difficulties remembering what they have seen. Our results suggest 
that positive placebos may lead to better retrieval of the witnessed event, 
without compromising memory accuracy. These practical issues deserve 
further investigation.
Notes
Correspondence about this article should be addressed to Kim van Oorsouw, de-
partment of Experimental Psychology, Maastricht University, P.O. Box 616, 6200 
Md, Maastricht, The Netherlands (e-mail: k.vanoorsouw@psychology.unimaas.nl). 
Received for publication October 20, 2005; revision received January 26, 2006.
 1. A subsequent analysis of memory performance of the remainder of partici-
pants who did not expect the drugs to be effective (n = 15 in the positive placebo 
group and n = 15 in the negative placebo group) yielded no between-group dif-
ferences on proportions of correctly recalled information, t(28) < 1.0, number 
of commission errors, t(28) < 1.0, or number of distortion errors, t(28) = 1.12, 
p = .27. This shows that beliefs people have about placebos are a crucial factor 
when it comes to the effectiveness they attribute to them.
 2. Two participants did not answer the question about how effective they believed 
the placebo would be. They were excluded from further analyses.
 3. Blood pressure measures for one participant were missing because of equip-
ment failure.
 4. Because both experimental groups were small, one could argue that the 
effects on free recall or distortion errors could have been caused by one or two 
participants with extreme free recall or distortion scores. To this end, z scores were 
calculated to locate participants with extreme scores (z < -2 or >2). When the 
two participants with extreme scores were excluded from the analysis, free recall 
scores were unaffected (p = .02, two-tailed). We did not remove outliers from our 
analyses of distortions because all participants made 0, 1, 2, or 3 distortion errors. 
Against this background, any definition of an outlier would be arbitrary.
 5. Interestingly, the opposite was true for the group that was excluded from the 
analysis because they did not believe the drug would be effective. In this group, 
there was a significant correlation between expected effect and reported effect, 
r = .60, p < .01. That is, pessimistic beliefs about the drug’s effectiveness in this 
group did affect their reports afterward.
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